Angiotensin (1-7) reduces intraocular pressure in the normotensive rabbit eye

Vaajanen A., Vapaatalo H., Kautiainen H., Oksala O.

2008
Investigative Ophthalmology and Visual Science

Therapeutic Area

Glaucoma
Categories

Preclinical development

Affiliations

Institute of Biomedicine, Pharmacology, University of Helsinki, Finland; Rheumatism Foundation Hospital, Heinola, Finland; Research and Development Division, Santen Oy, Tampere, Finland; Institute of Biomedicine, Pharmacology, University of Helsinki, PO Box 63, 00014 Helsinki, Finland

Related Publications

Associations between Clustered Visual Field Progression and Locations of Disc Hemorrhages in Glaucoma: A Three-year Prospective Study

Akagi T.; Fukuchi T.; Higashide T.; Udagawa S.; Ohkubo S.; Sugiyama K.; Tanihara H.; Araie M.; Tomita G.; Matsumoto C.; Tomidokoro A.; Hangai M.; Kawata H.; Inai M.; Tanaka Y.; SVF Prospector Study Group

Proteome-Wide Analysis of Autoantibodies in Open-Angle Glaucoma in Japanese Population: A Pilot Study

Takada N.; Ishikawa M.; Sato K.; Kunikata H.; Ninomiya T.; Hanyuda A.; Fukuda E.; Yamaguchi K.; Ono C.; Kirihara T.; Shintani C.; Tsusu C.; Osanai A.; Goshima N.; Izumi Y.; Zorumski C.F.; Nakazawa T.

Bioequivalence of Preservative-free and Preserved Omidenepag Isopropyl (OMDI) 0.002% Ophthalmic Solutions in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: Results from the Phase 3 DAISY Study

Aihara M.; Lu F.; Ikeda T.; Odani-Kawabata N.

View all Glaucoma publications